New Onset of Giant Cell Arteritis following ChAdOx1-S (Vaxevria®) Vaccine Administration
Vaccines
; 11(2), 2023.
Article
in English
| EuropePMC | ID: covidwho-2269506
ABSTRACT
We report a 78-year-old man presenting with persistent headaches in vertex and temporo-parietal area;fatigue, worsening after walking;jaw claudication;scotomas;pharyngodynia;and dry cough after the second dose of the SARS-CoV-2 vaccine (ChAdOx1-S) administration. Laboratory findings showed an elevated C-reactive protein level and FDG-CT PET showed evidence of active large vessel vasculitis with diffuse abnormal artery uptake. Under suspicion of vasculitis, a temporal arteries biopsy was performed;the histopathologic findings demonstrated the transmural inflammatory infiltrate with giant cells, compatible with giant cell arteritis. Although the overall incidence of vaccine-triggered autoimmunity is low, rheumatologists worldwide should be aware of autoimmune diseases as a new potential adverse event of vaccines.
Search on Google
Collection:
Databases of international organizations
Database:
EuropePMC
Topics:
Vaccines
Language:
English
Journal:
Vaccines
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS